Skip to content
Government TAS, Medical Health Aged Care

Pharmacists thank Rockliff for service to Health portfolio

Pharmaceutical Society of Australia (PSA) < 1 mins read

21 July 2023

The Pharmaceutical Society of Australia (PSA) has thanked Tasmanian Premier Jeremy Rockliff for his leadership of the health sector over his years as Health Minister. 

The Premier has announced today that he will step down as Health Minister, with a successor to be announced in the coming days. 

PSA Tasmanian President David Peachey MPS thanked the Premier, drawing on his commitment to expanding pharmacy practice to better serve Tasmanians. 

“Premier Rockliff has always been a great supporter of pharmacists, working with us to work closer to our top of scope and support the health of Tasmanians,” Mr Peachey said.

“We are proud to have worked with the Premier to progress the Review of pharmacists’ scope of practice in Tasmania, which will result in more health services being provided by pharmacists around our state.

“Under the Premier’s leadership Tasmanians have greater access to vaccinations through their local pharmacist and can also access a new supply of their medicines in an emergency through expanded continued dispensing. 

“These initiatives are having a real and positive impact on the health of our communities.”

“On behalf of all pharmacists in Tasmania, I thank the Premier for his service as Health Minister. 

“I look forward to continue working with him and his successor to continue work on supporting pharmacists’ scope of practice and ensuring that our primary care system delivers quality healthcare for all Tasmanians,” Mr Peachey concluded.


Media contact:   Georgia Clarke   M: 0480 099 798  E:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

More from this category

  • Environment, Medical Health Aged Care
  • 01/12/2023
  • 10:43
West Australian doctors peak bodies

WA doctors and health professionals call for the government to take urgent action on climate change and end fossil fuel expansion to protect health

On the 1st December, just prior to the COP28 Health Day on the 3rd December, representatives of the medical colleges for general practitioners (GPs), emergency doctors, rural and remote doctors, and surgeons, as well as other doctors and health professionals, gather at 8 am on the steps of Parliament House to call on the WA Government take urgent action on climate change and protect the health of Western Australians. Reiterating calls from medical colleges earlier this year in support of ending fossil fuel expansion and climate action, those gathered today ask the WA government to: End expansion of any new…

  • Medical Health Aged Care
  • 01/12/2023
  • 10:12
Australian Dental Industry Association

ADIA congratulates Senators of the Inquiry into the Provision of and Access to Dental Services in Australia

1 December The Australian Dental Industry Association congratulates the Senators of the Senate Select Committee Inquiry into the Provision of and Access to Dental…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 01/12/2023
  • 09:17

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune Aegros, an Australian clinical-stage biopharmaceutical company leader in the development and manufacture of plasma derived medicinal products (PDMPs), today announced positive top-line interim results from its CHAT clinical trial. Top-line interim results indicate that Aegros’ COVID-19 hyperimmune provides higher levels of antibodies compared to high-titer convalescent plasma. These results are in line with Aegros’ pre-clinical expectations. CHAT compared Aegros’ COVID-19 hyperimmune to COVID-19 convalescent plasma. The hyperimmune was manufactured using Aegros’ patented Haemafrac® process. A hyperimmune is an intravenous immunoglobulin rich in antibodies that can provide passive immunity for…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.